PL2632550T3 - Sposoby i kompozycja do leczenia biegunki związanej z HIV - Google Patents

Sposoby i kompozycja do leczenia biegunki związanej z HIV

Info

Publication number
PL2632550T3
PL2632550T3 PL11837249T PL11837249T PL2632550T3 PL 2632550 T3 PL2632550 T3 PL 2632550T3 PL 11837249 T PL11837249 T PL 11837249T PL 11837249 T PL11837249 T PL 11837249T PL 2632550 T3 PL2632550 T3 PL 2632550T3
Authority
PL
Poland
Prior art keywords
compositions
methods
treating hiv
associated diarrhea
diarrhea
Prior art date
Application number
PL11837249T
Other languages
English (en)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2632550(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of PL2632550T3 publication Critical patent/PL2632550T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL11837249T 2010-10-31 2011-10-31 Sposoby i kompozycja do leczenia biegunki związanej z HIV PL2632550T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
EP11837249.9A EP2632550B1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (1)

Publication Number Publication Date
PL2632550T3 true PL2632550T3 (pl) 2017-10-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11837249T PL2632550T3 (pl) 2010-10-31 2011-10-31 Sposoby i kompozycja do leczenia biegunki związanej z HIV

Country Status (20)

Country Link
US (4) US8962680B2 (pl)
EP (1) EP2632550B1 (pl)
JP (2) JP6063385B2 (pl)
CN (2) CN107595836A (pl)
AU (1) AU2011320155B2 (pl)
BR (1) BR112013010774A2 (pl)
CA (1) CA2816416C (pl)
DK (1) DK2632550T3 (pl)
EC (1) ECSP13012650A (pl)
ES (1) ES2635435T3 (pl)
HK (1) HK1249036A1 (pl)
HU (1) HUE035393T2 (pl)
MX (1) MX348184B (pl)
PE (1) PE20140036A1 (pl)
PH (1) PH12013500857A1 (pl)
PL (1) PL2632550T3 (pl)
PT (1) PT2632550T (pl)
RU (1) RU2597746C2 (pl)
WO (1) WO2012058664A1 (pl)
ZA (1) ZA201303136B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2007130892A2 (en) 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
EP2529626B1 (en) * 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
MX2015007065A (es) * 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
IL270984B2 (en) 2017-05-31 2026-05-01 Napo Pharmaceuticals Inc Methods and preparations for treating congenital diarrheal disorder
WO2018222921A1 (en) 2017-05-31 2018-12-06 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
IL299028A (en) * 2020-06-19 2023-02-01 Napo Pharmaceuticals Inc Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP0935417B1 (en) 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
CA2667449A1 (en) * 2005-06-22 2007-01-04 University Of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
WO2007068383A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
EP2529626B1 (en) 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
WO2007130892A2 (en) * 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2010021681A2 (en) 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
JP2013506716A (ja) * 2009-10-06 2013-02-28 ザ レゲンツ オブ ジ ユニヴァーシティ オブ カリフォルニア クロフェレマーなどのプロアントシアニジンオリゴマーを用いて疾患を治療する方法
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
MY197454A (en) 2011-12-22 2023-06-19 Napo Pharmaceuticals Inc Non-enteric pharmaceutical composition comprising crofelemer
MX2015007065A (es) 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.

Also Published As

Publication number Publication date
HUE035393T2 (en) 2018-05-02
EP2632550A1 (en) 2013-09-04
JP2013540826A (ja) 2013-11-07
US20120107370A1 (en) 2012-05-03
JP6063385B2 (ja) 2017-01-18
DK2632550T3 (en) 2017-08-07
WO2012058664A1 (en) 2012-05-03
BR112013010774A2 (pt) 2017-03-21
US8962680B2 (en) 2015-02-24
CN103370101A (zh) 2013-10-23
HK1249036A1 (zh) 2018-10-26
PT2632550T (pt) 2017-08-02
ECSP13012650A (es) 2013-10-31
PE20140036A1 (es) 2014-01-31
JP6310971B2 (ja) 2018-04-11
AU2011320155A1 (en) 2013-05-09
US20120184605A1 (en) 2012-07-19
PH12013500857A1 (en) 2018-01-17
EP2632550B1 (en) 2017-05-03
US20140294903A1 (en) 2014-10-02
MX348184B (es) 2017-06-02
US9585868B2 (en) 2017-03-07
EP2632550A4 (en) 2014-04-23
CA2816416C (en) 2020-02-11
RU2597746C2 (ru) 2016-09-20
US20150190367A1 (en) 2015-07-09
ES2635435T3 (es) 2017-10-03
MX2013004873A (es) 2013-08-21
CN107595836A (zh) 2018-01-19
RU2013123794A (ru) 2014-12-10
CA2816416A1 (en) 2012-05-03
JP2017019806A (ja) 2017-01-26
ZA201303136B (en) 2016-01-27
AU2011320155B2 (en) 2016-02-25

Similar Documents

Publication Publication Date Title
ZA201303423B (en) Compositions and methods for treating myelofibrosis
ZA201303136B (en) Methods and composition for treating hiv-associated diarrhea
IL239918A0 (en) Preparations for the treatment of colitis
SG2014010706A (en) Method and composition
ZA201302625B (en) Methods and compositions for treating hemophilia b
GB201016001D0 (en) Composition and method
ZA201502618B (en) Compositions and methods for treating proteinopathies
IL234829A0 (en) Methods and preparations for treating inflammation
SI2552484T1 (sl) Postopki in sestavki za znižanje ravni paratiroidnega hormona
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
AP3941A (en) Materials and methods for treating diarrhea
IL216146A0 (en) Methods and compositions for treating lupus
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
IL232648A0 (en) Preparations and methods for treating glioma
GB201003531D0 (en) Composition and method
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
GB201018650D0 (en) Methods and compositions
GB201008364D0 (en) Composition and method
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
GB201008843D0 (en) Method and composition
PL2606032T3 (pl) Kompozycja i sposoby terapii glejakaep
GB2500357B (en) Combination and composition for treating obesity
EP2603610A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A LUPUS
GB201116803D0 (en) Method and compositions for treating cutaneous verrucae
HK1255654A (en) Compositions and methods for treating myelofibrosis